Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency
dc.authorscopusid | 31767766600 | en_US |
dc.authorwosid | CDM-6595-2022 | en_US |
dc.contributor.author | Gayete-Lafuente, Sonia | |
dc.contributor.author | Turan, Volkan | |
dc.contributor.author | Oktay, Kutluk H. | |
dc.date.accessioned | 2023-09-18T06:30:29Z | |
dc.date.available | 2023-09-18T06:30:29Z | |
dc.date.issued | 2023 | en_US |
dc.department | Fakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalı | en_US |
dc.description.abstract | Purpose To assess the feasibility and outcomes of oocyte cryopreservation with in vitro maturation (IVM) in post-pubertal girls undergoing fertility preservation (FP) for primary ovarian insufciency (POI) risk. Methods Ovarian stimulation was performed with an antagonist protocol or progesterone priming. Ultrasound monitoring was performed transabdominally. Oocytes were retrieved transvaginally under IV sedation. Immature oocytes were subjected to IVM for up to 36 h. All MII oocytes were vitrifed. The main outcome measure was the total number of mature oocytes cryopreserved. The secondary outcome was the increase in the mature oocyte yield after IVM. Results Indications for FP included mosaic Turner syndrome (mTS; n=10), malignancy (n=3), and POI risk (n=2). The mean±SD age, antral follicle count (AFC), and AMH levels were 14.2±1.4 years, 8±5.2 and 1.3±1.3 ng/mL. In girls with mTS, the ovarian reserve was low for age (AFC 7.4±4.7 and AMH 1.4±1.6 ng/mL). Oocyte cryopreservation was possible in all girls with a range of 1–27 mature oocytes obtained, even in those who were previously exposed to chemotherapy or with low ovarian reserve, and no surgical complications were encountered. After IVM, the median mature oocyte yield increased signifcantly from 7.5 to 10.5 (p=0.001). Conclusions Oocyte cryopreservation appears to be feasible and safe in girls as young as 12 years of age at risk for POI The utility of IVM increases the yield of cryopreserved mature oocytes. Prior exposure to chemotherapy or low ovarian reserve should not be an automatic reason to exclude these girls from FP consideration. | en_US |
dc.description.sponsorship | K.O. is funded by NIH HD R01HD053112. | en_US |
dc.identifier.citation | Gayete-Lafuente, S., Turan, V., & Oktay, K. H. (2023). Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency. Journal of Assisted Reproduction and Genetics, 40(12), pp. 2777-2785. https://doi.org/10.1007/s10815-023-02932-7 | en_US |
dc.identifier.doi | 10.1007/s10815-023-02932-7 | en_US |
dc.identifier.endpage | 2785 | en_US |
dc.identifier.issn | 1058-0468 | en_US |
dc.identifier.issn | 1573-7330 | en_US |
dc.identifier.issue | 12 | en_US |
dc.identifier.pmid | PMID: 37715873 | en_US |
dc.identifier.scopus | 2-s2.0-85171259065 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 2777 | en_US |
dc.identifier.uri | https://doi.org/10.1007/s10815-023-02932-7 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13055/540 | |
dc.identifier.volume | 40 | en_US |
dc.identifier.wos | WOS:001069073100001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak.other | SCI-E - Science Citation Index Expanded | en_US |
dc.institutionauthor | Turan, Volkan | |
dc.language.iso | en | en_US |
dc.publisher | Springer/Plenum Publishers | en_US |
dc.relation.ispartof | Journal of Assisted Reproduction and Genetics | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Oocyte Cryopreservation | en_US |
dc.subject | In Vitro Maturation | en_US |
dc.subject | Fertility Preservation | en_US |
dc.subject | Ovarian Insufciency | en_US |
dc.subject | Turner Syndrome | en_US |
dc.subject | Post-Pubertal Children | en_US |
dc.title | Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Dosyalar
Orijinal paket
1 - 1 / 1
Kapalı Erişim
- İsim:
- Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.pdf
- Boyut:
- 601.58 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Kapalı Erişim
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: